Introduction to Home Science and Food Nutrition If you've completed your 12th grade and are seeking a course that combines ...

AI assistants have arrived at a time when teachers need support to do their best work. In a national survey by the RAND ...

David J. Adams serves as Indiana’s Secretary of Commerce and a member of Governor Mike Braun’s cabinet. Since his appointment in 2025, Adams has been instrumental in the transforming the state’s ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

The U.S. life sciences industry entered 2026 with surprising momentum, following threats of tariffs and disrupted trade, NIH funding cuts, and a sluggish IPO market. Accounting for more than ...

April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge and scientific research capabilities, as the startup deepens its push into the ‌life ...

SAN SALVADOR — Salvadoran President Nayib Bukele on Wednesday signed into law constitutional reforms to permit life prison sentences for people as young as 12, a contentious reform that follows other ...

El Salvador has published a new law that will allow authorities to penalise minors as young as 12 with life imprisonment for severe crimes, including homicide, terrorism or rape. On Tuesday, the ...

Pac-12 executives are gathering this week at Oregon State for three days of meetings that will address a barrage of topics but are not expected to produce significant news. Key outstanding issues in ...

One of the world’s leading investment firms has broken its own record with the closing of its $6.3 billion Blackstone Life Sciences VI (BLXS VI) fund, which is 40% larger than its predecessor.

Blackstone Inc. closed its latest life-sciences fund with $6.3 billion of commitments, the firm’s biggest haul for backing clinical trials of medicines and technologies. The new vehicle, Blackstone ...

March 26 (Reuters) - Wave Life Sciences (WVE.O), opens new tab shares plunged 58% on Thursday after a higher dose of its experimental obesity ‌drug failed to show a clear improvement at reducing a ...